SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ALLR

Allarity Therapeutics Inc.
NASDAQHealth Care

Latest close: 0.89 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 29, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record3703 flagged findings
Reported transactions (Form 4)22since Sep 30, 2024 · and 1 other holding
Corporate events (8-K)30since Feb 1, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-15share offering or dilution eventrecentOpen filing ↗
    “…our intellectual property portfolio, the manufacturing of clinical and research material, hiring personnel, raising capital and…”
    +1 more passage from the same document
    • “…of $ 2,000 . As of March 31, 2026, $ 5.998 million remained available under the equity line of credit. No liability or…”
  • 2026-05-15capital return (buybacks/dividends)recentOpen filing ↗
    “…within that period. The Company was in compliance with all material terms of the Note Purchase Agreement as of March 31, 2026.…”
    +1 more passage from the same document
    • “…terms of the Note Purchase Agreement as of March 31, 2026. For the three months ended March 31, 2026, the A- 1 Note and B Note…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 370)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 26Form 4 ↗Insider transaction
  • Oct 1, 268-K ↗Current report · Other events
  • Sep 29, 268-K ↗Current report · Other events
  • Sep 16, 268-K ↗Current report · Other events
  • Sep 14, 268-K ↗Current report · Other events
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 268-K ↗Current report · Results
  • Jul 1, 268-K ↗Current report · Shareholder vote results · Other events
  • Jun 22, 268-K ↗Current report · Other events
  • Jun 2, 268-K ↗Current report · A senior executive left or was appointed
  • May 15, 2610-Q ↗Quarterly report
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • May 11, 26Form 3 ↗Insider transaction
  • May 8, 268-K ↗Current report · Communication to the market · Other events
  • May 7, 26Form 4 ↗Insider transaction
  • May 6, 268-K ↗Current report · Other events
  • Apr 30, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 30, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 30, 26Form 4/A ↗Insider transaction · amendment
  • Apr 30, 26Form 4 ↗Insider transaction
  • Apr 28, 268-K ↗Current report · Other events
  • Apr 27, 26424B3 ↗Securities offering
  • Apr 24, 26S-3/A ↗Securities offering · amendment
  • Apr 22, 26CORRESP ↗Correspondence with the SEC

370 filings on record, the oldest from Aug 20, 21.

Listing the 25 most recent filings of the 370 on record.

8-Ks, explained

Stress17Structure54Governance26
  • Jun 2, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 6, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 29, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Dec 23, 25StructureSold unregistered shares8-K 3.02 ↗
  • Dec 8, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Sep 22, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2024 – 2025show all 4hide
    • Jul 7, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jun 11, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 16, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Oct 4, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Sep 13, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Sep 10, 24GovernanceA senior executive left or was appointed+4 more in the same filing8-K/A 5.02 ↗
  • Sep 9, 24GovernanceA senior executive left or was appointed+4 more in the same filing8-K 5.02 ↗
  • Aug 21, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jun 21, 24StressListing notice (8-K 3.01)8-K 3.01 ↗

8 older filings not shown · The record reaches back to Dec 10, 21.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Nov 17, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Oct 30, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jul 27, 23StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • May 26, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 12, 23StressListing notice (8-K 3.01)+4 more in the same filing8-K 3.01 ↗
  • Feb 10, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 6, 23StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Dec 23, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 18, 22StressPast accounts declared unreliable and being restated+3 more in the same filing8-K 4.02 ↗

The full record holds 17 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).

Stock compensation, tax and giftsshow the 16 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 30, 26Compensationamount n/aJeremy R. GraffSee Remarks↗
  • Sep 30, 26Tax$14KJeremy R. GraffSee Remarks↗
  • Jan 28, 26Compensationamount n/aJeffrey S ErvinCFO↗
  • Jan 28, 26Compensationamount n/aJeremy R. GraffSee Remarks↗
  • Jan 28, 26Compensationamount n/aGerald W. McLaughlin↗
  • Jan 28, 26Compensationamount n/aThomas JensenCEO↗
  • Jan 22, 26Compensationamount n/aJeremy R. GraffSee Remarks↗
  • Jan 22, 26Tax$21KJeremy R. GraffSee Remarks↗
  • Jan 7, 26Compensationamount n/aJeremy R. GraffSee Remarks↗
  • Jan 7, 26Compensationamount n/aJesper Hoeiland↗
  • Sep 30, 25Compensationamount n/aJeremy R. GraffSee Remarks↗
  • Sep 30, 25Tax$23KJeremy R. GraffSee Remarks↗
  • Jan 22, 25Compensationamount n/aThomas JensenCEO↗
  • Jan 22, 25Compensationamount n/aAlexander EpshinskyCFO↗
  • Jan 22, 25Compensationamount n/aJeremy R. GraffCDO↗
  • Sep 30, 24Compensation$250KJeremy R. GraffSee Remarks↗

The full record holds 16 transactions and goes back to Sep 12, 24.

Its sector and its market

Allarity Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Allarity Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Allarity Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
370 documents on file, from Aug 20, 2021 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.